Works matching IS 00219738 AND DT 2004 AND VI 114 AND IP 4


Results: 23
    2
    3
    4
    7
    8
    9
    10
    11
    12

    Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

    Published in:
    Journal of Clinical Investigation, 2004, v. 114, n. 4, p. 529, doi. 10.1172/JCI200421109
    By:
    • Lemin Zheng;
    • Nukuna, Benedicta;
    • Brennan, Marie-Luise;
    • Mingjiang Sun;
    • Goormastic, Marlene;
    • Settle, Megan;
    • Schmitt, Dave;
    • Xiaoming Fu;
    • Thomson, Leonor;
    • Fox, Paul L.;
    • Ischiropoulos, Harry;
    • Smith, Jonathan D.;
    • Kinter, Michael;
    • Hazen, Stanley L.
    Publication type:
    Article
    13
    14

    Foxa2 regulates multiple pathways of insulin secretion.

    Published in:
    Journal of Clinical Investigation, 2004, v. 114, n. 4, p. 512, doi. 10.1172/JCI200421149
    By:
    • Lantz, Kristen A.;
    • Vatamaniuk, Marko Z.;
    • Brestelli, John E.;
    • Friedman, Joshua R.;
    • Matschinsky, Franz M.;
    • Kaestner, Klaus H.
    Publication type:
    Article
    15
    16
    17
    18
    20
    21
    22
    23

    High-tech coal mine canary.

    Published in:
    Journal of Clinical Investigation, 2004, v. 114, n. 4, p. 448, doi. 10.1172/JCI22768
    By:
    • Goodman, Laurie
    Publication type:
    Article